D-1852-2019 Class II Terminated
FDA drug recall D-1852-2019 was initiated by Pfizer Inc. on Sep 6, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Mar 25, 2023). Affected quantity: 185,700 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 18, 2019
- Initiation Date
- Sep 6, 2019
- Termination Date
- Mar 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 185,700 vials
Product description
Bacteriostatic Water for Injection, USP, 30 mL vials, Rx only, Mfd. for: Hospira, Inc., Lake Forest, IL 60045 USA. NDC Vial: 0409-3977-01; NDC Carton: 0409-3977-03
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Nationwide US and Puerto Rico
Code information
Lot #: W20308, Exp. Dec 1, 2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1852-2019
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.